Theralase Technologies Inc. V.TLT

Me not smart...

[thadeush]

but this latest news about the herpes virus is incredible. It adds to what already appears to be a whole other treatment area for TLT - that of eradicating viruses in the body, SARSCOVID2 included, for which there is currently no cure or even effective treatment. I wouldn't be surprised if these blood treatments are eventually spun off from the cancer treatments as a powerful separate opportunity.

[CancerSlayer]

Menosome (not to be confused with menoalittle)...& that is, the specialized mechanism of action(s) utilized in our modifiable ruthenium-based drug gives it the ability/potential to treat so many unmet conditions in both the oncology & infectious disease spaces.  When comparing our drug tech to the current SOC for the above spaces, the potential here seems unmatched imo. Chemo &

[O12009]

  GSK discontinues herpes vaccine  The British pharma said its shot didn’t show desired efficacy in a Phase 2 study. Elsewhere, Pulmovant has plans to advance a drug licensed from Bayer. GSK will not advance an experimental vaccine for the herpes simplex virus after reviewing data from a Phase 2 trial, the company said Wednesday. While no safety concerns were reported, GSK

[Tarbaby]

Lets all hope Roger and Dr.Mandel go visit GSK asap with their test data for eliminating HSV and other viruses.. And xray triggered Rutherrin for various cancers..and..  and.. and...

[O12009]

They would be a good candidate to buy our rights to develop Herps vaccine. Of course if they want more it all depends on $$$ and who they would be competing against for the rights. We are not a one horse pony and the rights to our my different revenue streams will bring lots of bidders or one major player.

[CancerSlayer]

Yep...and based on all of the data/research performed to date re: ruthenium-based compounds, it's not unreasonable to conclude that systemic Rutherrin (activated by x-ray/metformin) could potentially replace platinum-based chemo (i.e. cisplatin) as the first-line SOC for multiple cancer types, including its current use for more advanced stages of bladder cancer. It's hard to believe that

[Tarbaby]

I agree with you 100%.Ruthenium might replace platinum for cancer treatment....But first Dr Mandel must demonstrate that Ruthenium based compounds like Rutherrin can be safe to inject into humans at the low doses required without serious side effects. With all the money they have rsised over the decade or more why have they not done that yet..